ATC code G04

ATC codes
G Genito-urinary system and sex hormones
G01 Gynecological antiinfectives and antiseptics
G02 Other gynecologicals
G03 Sex hormones and modulators of the genital system
G04 Urologicals
ATCvet only
QG51 Antiinfectives and antiseptics for intrauterine use
QG52 Products for teats and udder
A B C D G H QI J L M N P R S V (Hover over links to see titles)

ATC code G04 Urologicals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>

ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.

</ref><ref>

ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.

</ref> Subgroup G04 is part of the anatomical group G Genito-urinary system and sex hormones.<ref>

ATC/DDD Index 2022

code G04(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QG04.<ref>

ATCvet Index 2022

code QG04(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref> ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

G04B Urologicals

G04BA Acidifiers

G04BA01 Ammonium chloride

G04BA03 Calcium chloride

QG04BA90 Methionine

G04BC Urinary concrement solvents

Empty group

G04BD Drugs for urinary frequency and incontinence

G04BD01 Emepronium

G04BD02 Flavoxate

G04BD03 Meladrazine

G04BD04 Oxybutynin

G04BD05 Terodiline

G04BD06 Propiverine

G04BD07 Tolterodine

G04BD08 Solifenacin

G04BD09 Trospium

G04BD10 Darifenacin

G04BD11 Fesoterodine

G04BD12 Mirabegron

G04BD13 Desfesoterodine

G04BE Drugs used in erectile dysfunction

G04BE01 Alprostadil

G04BE02 Papaverine

G04BE03 Sildenafil

G04BE04 Yohimbin

G04BE06 Moxisylyte

G04BE07 Apomorphine

G04BE08 Tadalafil

G04BE09 Vardenafil

G04BE10 Avanafil

G04BE11 Udenafil

G04BE30 Combinations

G04BE52 Papaverine, combinations

QG04BQ Urinary alkalizers

QG04BQ01 Sodium bicarbonate

G04BX Other urologicals

G04BX01 Magnesium hydroxide

G04BX03 Acetohydroxamic acid

G04BX06 Phenazopyridine

G04BX10 Succinimide

G04BX11 Collagen

G04BX12 Phenyl salicylate

G04BX13 Dimethyl sulfoxide

G04BX14 Dapoxetine

G04BX15 Pentosan polysulfate sodium

G04BX16 Tiopronin

QG04BX56 Phenazopyridine, combinations

QG04BX90 Ephedrine

QG04BX91 Phenylpropanolamine

G04C Drugs used in benign prostatic hypertrophy

G04CA Alpha-adrenoreceptor antagonists

G04CA01 Alfuzosin

G04CA02 Tamsulosin

G04CA03 Terazosin

G04CA04 Silodosin

G04CA51 Alfuzosin and finasteride

G04CA52 Tamsulosin and dutasteride

G04CA53 Tamsulosin and solifenacin

G04CB Testosterone-5-alpha reductase inhibitors

G04CB01 Finasteride

G04CB02 Dutasteride

G04CX Other drugs used in benign prostatic hypertrophy

G04CX01 Prunus africanae cortex

G04CX02 Sabalis serrulatae fructus

G04CX03 Mepartricin

G04CX04 Fexapotide

QG04CX90 Osaterone